Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

NCT: NCT05376267 · RECRUITING

NCT IDNCT05376267
StatusRECRUITING
Start Date2022-08-05
Completion2028-03-31

Brief Summary

This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest. The study team hypothesizes that longer durations of cooling may improve either the proportion of children that attain a good neurobehavioral recovery or may result in better recovery among the proportion already categorized as having a good outcome.

Frequently Asked Questions

What is Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)?

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) is a clinical trial registered under NCT05376267. Current status: RECRUITING.

What is the status of NCT05376267?

The current status of NCT05376267 (Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)) is: RECRUITING.

When did Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) start?

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) started on 2022-08-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑